Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis Main Article Content Andreas Wollenberg Emma Guttman-Yassky Mathias Torpet Jonathan I Silverberg Keywords Abstract Abstract not available. Disclosures: Study sponsored by LEO Pharma. Copyright 2018 SKIN Article Sidebar Poster PDF Published Dec 17, 2018 DOI https://doi.org/10.25251/skin.2.supp.63 Article Details How to Cite Wollenberg, A., Guttman-Yassky, E., Torpet, M., & Silverberg, J. I. (2018). Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. SKIN The Journal of Cutaneous Medicine, 2, S63. https://doi.org/10.25251/skin.2.supp.63 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Issue Vol. 2 (2018): Supplemental Issue: Scientific Posters & Abstracts Presented at 2018 Fall Clinical Dermatology Conference®-Las Vegas Section Atopic Dermatitis This work is licensed under a Creative Commons Attribution 4.0 International License. Authors transfer copyright to the publisher as part of the journal publishing agreement.All reprints are subject to the reprint policy.